In Brief: U.S. Surgical buys Japanese distributor
This article was originally published in The Gray Sheet
U.S. Surgical buys Japanese distributor: USSC completes acquisition of its Tokyo-based Japanese distributor, Auto Suture Japan, in a cash transaction valued at approximately $61 mil. The deal includes a $12 mil. downpayment made earlier this year, "with the balance to be paid over seven years, interest free," the company says. Auto Suture Japan's "135-person fully trained field sales organization" and other personnel will join USSC's workforce. The company also acquires inventory and "a state-of-the-art laparoscopic training center near Tokyo." USSC estimates the distributor's "current annualized business" to be in the $100 mil. range "with a strong pretax margin," noting that the acquisition "began adding more than $50 mil. in annualized incremental revenue during the second quarter of this year"...
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.